Breakthrough fights chemo hair loss

A research team has found a new way to boost the effectiveness of scalp cooling for chemotherapy patients.

Scientists at Sheffield Hallam University, working with scalp cooling pioneers Paxman, have discovered that combining antioxidant treatments with cooling can reduce chemotherapy-related hair follicle damage by up to 70 per cent.

Researchers say the breakthrough could lead to more consistent results from scalp cooling, a method already used by around 65 per cent of chemotherapy patients to help prevent hair loss.

They added the study showed optimal cooling at 18°C offers strong protection, but even sub-optimal cooling at 26°C became more effective when combined with antioxidants such as N-Acetylcysteine or Resveratrol, which reduce harmful molecules called reactive oxygen species that are triggered by chemotherapy and damage hair follicles.

Rich Paxman, chief executive of Paxman Scalp Cooling, said: “Our vision has always been to make our chemotherapy side-effect management technology available to everyone. 

“Our partnership with Sheffield Hallam University has been central to achieving this vision. 

“We are incredibly grateful for the team’s dedication and insight, and we are already working together on the next steps to translate this work into real-world solutions.”

The findings build on more than a decade of research led by Dr Nik Georgopoulos, and mark a promising step toward making hair loss prevention more accessible, reliable and effective for patients worldwide.

Dr Georgopoulos, associate professor in cell biology and transforming lives fellow at Sheffield Hallam University, added: “Our findings suggest the combination of cooling and antioxidants could be a game-changer in preventing chemotherapy-induced hair loss, and could make a real difference to the lives of cancer patients worldwide.

“It highlights the potential for a more effective and accessible solution to a common and highly distressing side effect of cancer treatment. 

“By improving the quality of life for these patients, this method represents a significant advancement in supportive cancer care.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.